Estrogen receptor-regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocarcinoma and precancerous lesions

Cancer Letters

Volumn 314, Issue 2, 2012, Pages 155-165

  Zhang, Rong ^a   He, Yifeng ^b   Zhang, Xueli ^a   Xing, Baolin ^c   Sheng, Youhua ^a   Lu, Huan ^a   Wei, Zhenhong ^a  

^a Fengxian Central Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Changzhou Women's and Children's Hospital   (China)

Author keywords

BAX; BCL2; Estrogen receptor; MicroRNA; Type I endometrial carcinoma

Indexed keywords

CELL PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; LET 7 PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 27A; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; BAX PROTEIN, HUMAN; MIRNLET7 MICRORNA, HUMAN;

ADULT; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN RNA BINDING; RNA TRANSLATION; TRANSCRIPTION REGULATION; UPREGULATION; ADENOCARCINOMA; ENDOMETRIUM TUMOR; GENETICS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

ADENOCARCINOMA; ADULT; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, BCL-2; HUMANS; MICRORNAS; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN;

EID: 84862833021     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.027     Document Type: Article

References (35)

1. V. Jongen, J. Briët, R. Jong, K. Hoor, M. Boezen, A. Zee, H. Nijman, H. Hollema, Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer, Gynecol. Oncol. 112 (2009) 537-542.
2. Y. Zhang, Q. Liao, C. Chen, L. Yu, J. Zhao, Function of estrogen receptor isoforms a and b in endometrial carcinoma cells, Int. J. Gynecol. Cancer 16 (2006) 1656-1660.
3. J.V. Bokhman, Two pathogenetic types of endometrial carcinoma, Gynecol. Oncol. 15 (1983) 10-17.
4. R. O'Lone, M.C. Frith, E.K. Karlsson, U. Hansen, Genomic targets of nuclear estrogen receptors, Mol. Endocrinol. 18 (2004) 1859- 1875.
5. J.F. Boggess, C.-X. Zhou, V.L. Bae-Jump, P.A. Gehrig, Y.E. Whang, Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines, Gynecol. Oncol. 103 (2006) 417-424.
6. M.B. Jones, A.P. Houwink, B.K. Freeman, T.M. Greenwood, J.M. Lafky, W.L. Lingle, A. Berchuck, G.L. Maxwell, K.C. Podratz, N.J. Maihle, The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer, J. Soc. Gynecol. Invest. 13 (2006) 304-311.
7. H. Wu, Y. Chen, J. Liang, B. Shi, G. Wu, Y. Zhang, D. Wang, R. Li, X. Yi, H. Zhang, L. Sun, Y. Shang, Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis, Nature 438 (2005) 981-987.
8. P. Bhat-Nakshatri, G.-H. Wang, N.R. Collins, M.J. Thomson, T.R. Geistlinger, J.S. Carroll, M. Brown, S. Hammond, E.F. Srour, Y.-L. Liu, H. Nakshatri, Estradiol-regulated microRNAs control estradiol response in breast cancer cells, Nucl. Acids Res. 37 (2009) 4850- 4861.
9. M.L. Cleary, S.D. Smith, J. Sklar, Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation, Cell 47 (1986) 19-28.
10. Z.N. Oltvai, C.L. Milliman, S.J. Korsmeyer, Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell 74 (1993) 609-619.
11. T.E. Vaskivuo, F. Stenbäck, P. Karhumaa, J. Risteli, L. Dunkel, J.S. Tapanainen, Apoptosis and apoptosis-related proteins in human endometrium, Mol. Cell. Endocrinol. 165 (2000) 75-83.
12. H.O. Critchley, S. Tong, S.T. Cameron, T.A. Drudy, R.W. Kelly, D.T. Baird, Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo, J. Reprod. Fertil. 115 (1999) 389-395.
13. S. Shimizu, M. Narita, Y. Tsujimoto, Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC, Nature 399 (1999) 483-487.
14. S.W. Fesik, Y. Shi, Controlling the caspases, Science 294 (2001) 1477- 1478.
15. D. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber, S.J. Korsmeyer, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature 348 (1990) 334-336.
16. T.J. Mackey, A. Borkowski, P. Amin, S.C. Jacobs, N. Kyprianou, Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer, Urology 52 (1998) 1085-1090.
17. S. Krajewski, M. Krajewska, B.C. Turner, C. Pratt, B. Howard, J.M. Zapata, V. Frenkel, S. Robertson, Y. Ionov, H. Yamamoto, M. Perucho, S. Takayama, J.C. Reed, Prognostic significance of apoptosis regulators in breast cancer, Endocr. Relat. Cancer 6 (1999) 29-40.
18. M. Zhang, P. Zhang, C. Zhang, J. Sun, L. Wang, J. Li, Z. Tian, W. Chen, Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma, J. Oral Pathol. Med. 38 (2009) 307-313.
19. A. Faggiano, J.C. Sabourin, M. Ducreux, J. Lumbroso, P. Duvillard, S. Leboulleux, C. Dromain, A. Colao, M. Schlumberger, E. Baudin, Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features, Cancer 110 (2007) 265-274.
20. S. Kounelis, N. Kapranos, E. Kouri, D. Coppola, H. Papadaki, M.W. Jones, Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature, Mod. Pathol. 13 (2000) 379-388.
21. N. Sakuragi, A. Salah-eldin, H. Watari, T. Itoh, S. Inoue, T. Moriuchi, S. Fujimoto, Bax, Bcl-2, and p53 expression in endometrial cancer, Gynecol. Oncol. 86 (2002) 288-296.
22. C.M. Klinge, Estrogen regulation of microRNA expression, Curr. Genom. 10 (2009) 169-183.
23. P. Bhat-Nakshatri, G. Wang, N.R. Collins, M.J. Thomson, T.R. Geistlinger, J.S. Carroll, M. Brown, S. Hammond, E.F. Srour, Y. Liu, H. Nakshatri, Estradiol-regulated microRNAs control estradiol response in breast cancer cells, Nucl. Acids Res. 37 (2009) 4850- 4861.
24. L. Castellano, G. Giamas, J. Jacob, R.C. Coombes, W. Lucchesi, P. Thiruchelvam, G. Barton, L.R. Jiao, R. Wait, J. Waxman, G.J. Hannon, J. Stebbing, The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response, Proc. Natl. Acad. Sci. USA 106 (2009) 15732-15737.
25. S. Shimizu, T. Takehara, H. Hikita, T. Kodama, T. Miyagi, A. Hosui, T. Tatsumi, H. Ishida, T. Noda, H. Nagano, Y. Doki, M. Mori, N. Hayashi, The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma, J. Hepatol. 52 (2010) 698-704.
26. S. Ali, K. Almhanna, W. Chen, P.A. Philip, F.H. Sarkar, Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer, Am. J. Transl. Res. 28 (2010) 28-47.
27. K. Ohshima, K. Inoue, A. Fujiwara, K. Hatakeyama, K. Kanto, Y. Watanabe, K. Muramatsu, Y. Fukuda, S. Ogura, K. Yamaguchi, T. Mochizuki, Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line, PLoS One 5 (2010) e13247.
28. X. Zhong, N. Li, S. Liang, Q. Huang, G. Coukos, L. Zhang, Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells, J. Biol. Chem. 285 (2010) 41961-41971.
29. S. Peng, L.L. Chen, XX. Lei, L. Yang, H. Lin, G.G. Carmichael, Y. Huang, Genome-wide studies reveal that lin28 enhances the translation of genes important for growth and survival of human embryonic stem cells, Stem Cells 29 (2011) 496-504.
30. W. Koh, C.T. Sheng, B. Tan, Q.Y. Lee, V. Kuznetsov, L.S. Kiang, V. Tanavde, Analysis of deep sequencing microRNA expression profile from human embryonic stem cells derived mesenchymal stem cells reveals possible role of let-7 microRNA family in downstream targeting of hepatic nuclear factor 4 alpha, BMC Genom. 11 (Suppl. 1) (2010) S6.
31. E. Tili, J.J. Michaille, C.G. Liu, H. Alder, C. Taccioli, S. Volinia, G.A. Calin, C.M. Croce, GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFb effectors, Drosha and microRNAs with opposite oncogenic potentials, Nucl. Acids Res. 38 (2010) 7673-7688.
32. W.P. Tsang, T.T. Kwok, Let-7a microRNA suppresses therapeuticsinduced cancer cell death by targeting caspase-3, Apoptosis 13 (2008) 1215-1222.
33. S.M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K.L. Reinert, D. Brown, F.J. Slack, RAS is regulated by the let-7 microRNA family, Cell 120 (2005) 635-647.
34. S.M. Park, S. Shell, A.R. Radjabi, R. Schickel, C. Feig, B. Boyerinas, D.M. Dinulescu, E. Lengyel, M.E. Peter, Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2, Cell Cycle 6 (2007) 2585-2590.
35. A.M. Gassel, J. Backe, S. Krebs, S. Schön, H. Caffier, H.K. Müller-Hermelink, Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome, J. Clin. Pathol. 51 (1998) 25-29.